Angel Zerpa likely won't return until late next season, meaning that the Brewers' decision to tender him a contract would return them a few months' worth of production. Is that a worthwhile trade-off?
Reviewing the Brew's Brandon Glick argues that the Milwaukee Brewers face a difficult decision regarding pitcher Ángel Zerpa ahead of the November 20 non-tender deadline. Zerpa underwent Tommy John surgery in May and is projected to miss at least the first half of the 2027 season, leaving his 40-man roster spot in question.
Because players cannot be placed on the 60-day injured list during the offseason, Zerpa occupies an active roster spot while projected to earn $1.3 million in arbitration. Although the Brewers have roster flexibility with only 33 spots filled, Glick notes that upcoming free-agent signings, trades, and Rule 5 draft protections could jeopardize Zerpa's future with the team.
Get the latest sports news and top stories from MySportsTab delivered straight to your inbox.
No spam. Just the latest sports news and updates.
